Study of anger feelings in people with generalized anxiety
Part of Mental health clinical trials.
This trial studies how anger shows up in people who have symptoms of generalized anxiety. The goal is to learn more about these experiences in primary care, which could improve how care is tailored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have noticeable symptoms of generalized anxiety (checked with the GAD-Q-IV questionnaire).
- You can read and speak Swedish well enough to complete questionnaires and do an interview.
- If you’re already receiving treatment for generalized anxiety, it must be new or not yet helped much.
- You should not currently be in a mental health crisis that requires urgent specialized psychiatric care.
- You should not have known brain injury or dementia, and you should not have obvious alcohol or drug misuse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study in Swedish primary care tests a tailored treatment program (including exercise) for people with anxiety disorders. It aims to see if this approach helps reduce anxiety better than usual care.
This trial studies whether adding a Swedish self-help version of “CBT” (a structured talking-therapy approach) improves care for adults getting behavioral health support in primary care. It may help people who want support for mental health without needing fully guided therapy sessions.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This study observes people with generalized anxiety disorder to learn more about the condition. It may help improve future treatments.
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
This trial tests a new medicine called SYT-510 for adults with generalized anxiety disorder who are not currently taking medication. It aims to see if the drug reduces anxiety and is safe.
Hear when a new Generalized Anxiety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.